Literature DB >> 14552540

Corticoliberin protects neurons from the negative influences of "dysfunctins" in living olfactory cortex slices.

V G Shalyapina1, A A Mokrushin, N N Nesterov.   

Abstract

The protective effects of corticoliberin on living rat olfactory cortex slices during perfusion with "dysfunctins" extracted from cerebrospinal fluid of drug addicts were studied. Isolated perfusion of slices with medium containing "dysfunctins" led to irreversible suppression of the amplitude of individual components of focal potentials induced by electrical stimulation of the lateral olfactory tract. The maximum level of depression was seen for the AMPA and NMDA components of EPSP. Preliminary perfusion of slices with medium containing corticoliberin (100 nM) for 15 min partially, and for 30 min completely protected processes mediated by activation of AMPA and NMDA receptor mechanisms from the negative influences of "dysfunctins." It is suggested that corticoliberin can induce its protective effects either via its own specific receptors or non-specifically via glutamate receptors. It is also possible that both of these mechanisms act in combination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552540     DOI: 10.1023/a:1024421109805

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  21 in total

1.  [Biological testing for dysfunctins extracted by cerebrospinal fluid sorption in heroin addiction].

Authors:  P A Pirumov; V G Shaliapina; A A Mokrushin; D Iu Romanovskiĭ
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2000

2.  [Effect of intrastriatal administration of corticoliberin on behavioural components of stress].

Authors:  E V Turkina; E A Rybnikova; V V Rakitskaia; V G Shaliapina
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  1997 Jan-Feb

3.  Does corticotropin releasing factor act via a calcium-dependent mechanism?

Authors:  J B Aldenhoff
Journal:  Psychoneuroendocrinology       Date:  1986       Impact factor: 4.905

Review 4.  [Central mechanisms of predisposition to psychoactive substance dependence].

Authors:  I P Anokhina; N L Vekshina; A G Veretinskaia
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  1997

Review 5.  Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons.

Authors:  P V Piazza; M L Le Moal
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

6.  Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.

Authors:  F Rodríguez de Fonseca; M R Carrera; M Navarro; G F Koob; F Weiss
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

7.  [Dopaminergic mechanisms of the neostriatum in the corticoliberin regulation of adaptive behavior].

Authors:  V G Shaliapina; E A Rybnikova; V V Rakitskaia; E V Turkina
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  1998-10

8.  Buprenorphine and naloxone interactions in methadone maintenance patients.

Authors:  J Mendelson; R T Jones; S Welm; J Brown; S L Batki
Journal:  Biol Psychiatry       Date:  1997-06-01       Impact factor: 13.382

Review 9.  [Corticoliberinergic mechanisms of the neostriatum in the neuroendocrine stress regulation].

Authors:  V G Shaliapina; E A Rybnikova; V V Rakitskaia
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2000-11

10.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.